A Multi-centre, Open-label, Uncontrolled, First-in-Human Study to Evaluate the Safety and Tolerability and Explore the Efficacy of PeproStat in Gelita-Spon® Gelatin Sponge in Subjects Undergoing Open Liver Resection Surgery
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2015
Price : $35 *
At a glance
- Drugs PeproStat (Primary)
- Indications Perioperative haemorrhage
- Focus Adverse reactions; First in man
- Sponsors Haemostatix
- 20 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
- 18 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.